Search for Terms or Answers
Patient on bisphosphonates for several years, later placed on denosumab. After her 2nd dose, she developed ONJ. Patient then placed on daily teriparatide with resolution of ONJ and now has a normal BMD. She is about to complete her 2nd year of PTH therapy. What should she be treated with after PTH?
The hydroxychloroquine story begins in 1638 when the wife of the Viceroy of Peru, Countess Cinchona, acquired malaria while living in the New World.
The last in a four-part series from the CCF's Biologic Therapies Summit, we examine how to reduce CV risks in practice plus the current status of vasulitis management and the role biologics may play.
Part III covers talks on H. Zoster, biologics and SpA.
Rheumatologists should have a working knowledge on what vaccinations their patients need. The top 5 things rheumatologists should know about vaccines are...
Part II highlights from the Cleveland Clinic's Biologic Therapies Summit.
Many of us in academic centers, for better and worse, have had more and longer experience with EMRs than some of our colleagues in practice.
Highlights and take-home messages from the Cleveland Clinic Center for Continuing Education's Biologic Therapies Summit held this week (April 30 – May 2, 2015).
While the FRAX is useful to determine if individuals with low bone mass may benefit from treatment for osteoporosis, this method also has some shortcomings.
Experience is a great teacher. My experience with knee replacement surgery has taught me the integral importance of the physical therapist in individual outcomes.
In January 2014 the ACR convened a "Reproductive Health Summit" in Washington, DC to examine our understanding and knowledge of Pregnancy and Lactation issues in women with Rheumatic diseases. Key Stakeholders from the FDA, NIH, Womens advocacy groups, Dermatology, Gastrenterology, ACR and Pharma were asked to discuss what is know and what our unmet needs are.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
